P
0.047
0.00 (2.17%)
| Previous Close | 0.046 |
| Open | 0.047 |
| Volume | 115,110 |
| Avg. Volume (3M) | 810,454 |
| Market Cap | 28,129,828 |
| Price / Sales | 6.55 |
| Price / Book | 2.66 |
| 52 Weeks Range | |
| Earnings Date | 27 Aug 2024 |
| Profit Margin | -21.86% |
| Operating Margin (TTM) | -3.95% |
| Quarterly Revenue Growth (YOY) | 59.60% |
| Total Debt/Equity (MRQ) | 1.50% |
| Current Ratio (MRQ) | 1.37 |
| Operating Cash Flow (TTM) | 3.21 M |
| Levered Free Cash Flow (TTM) | 5.90 M |
| Return on Assets (TTM) | 0.46% |
| Return on Equity (TTM) | 0.50% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (AU) | Mixed | Mixed |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | PHARMX FPO [PHX] | - | - |
AIStockmoo Score
0.8
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 4.0 |
| Average | 0.75 |
|
PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 56.17% |
| % Held by Institutions | 7.72% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |